Skip to main content
Top
Published in: Heart and Vessels 12/2020

01-12-2020 | Atrial Fibrillation | Original Article

Circulating intermediate monocytes and toll-like receptor 4 correlate with low-voltage zones in atrial fibrillation

Authors: Hideya Suehiro, Koji Fukuzawa, Naofumi Yoshida, Kunihiko Kiuchi, Mitsuru Takami, Tomomi Akita, Tokiko Tabata, Makoto Takemoto, Jun Sakai, Toshihiro Nakamura, Atsusuke Yatomi, Hiroyuki Takahara, Yusuke Sonoda, Kazutake Nakasone, Kyoko Yamamoto, Atsushi Suzuki, Tomoya Yamashita, Ken-ichi Hirata

Published in: Heart and Vessels | Issue 12/2020

Login to get access

Abstract

Inflammation has been suggested to play a key role in the pathogenesis of atrial fibrillation (AF). Our hypothesis was that this inflammation, mediated by intermediate monocytes and toll-like receptor 4 (TLR4), causes the formation and expansion of low-voltage zones (LVZs). Prior to ablation, the monocyte subsets of 78 AF patients and TLR4 expression of 66 AF patients were analyzed via a flow cytometric analysis. Based on the CD14/CD16 expression, the monocytes were divided into three subsets: classical, intermediate, and non-classical. At the beginning of the ablation session, voltage mapping was performed. LVZs were defined as all bipolar electrogram amplitudes of < 0.5 mV. Correlations between the flow cytometric analysis results and presence of LVZs, as well as the total area of the LVZ, were examined. Patients with LVZs clearly had a higher proportion of intermediate monocytes (10.0 ± 3.6% vs. 7.2 ± 2.7%, p < 0.001) than those without LVZs. TLR4 was much more frequently expressed in the intermediate monocytes than other two monocyte subsets (p < 0.001). Moreover, the TLR4 expression level in intermediate monocytes correlated positively with the total area of the LVZs (r = 0.267, p = 0.030), especially in patients with paroxysmal AF (r = 0.365, p = 0.015). The intermediate monocytes and TLR4 expression positively correlated with LVZs in AF patients.
Literature
1.
go back to reference Li J, Solus J, Chen Q, Rho YH, Milne G, Stein CM, Darbar D (2010) Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm 7:438–444CrossRefPubMed Li J, Solus J, Chen Q, Rho YH, Milne G, Stein CM, Darbar D (2010) Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm 7:438–444CrossRefPubMed
2.
go back to reference Guo Y, Lip GY, Apostolakis S (2012) Inflammation in atrial fibrillation. J Am Coll Cardiol 60:2263–2270CrossRefPubMed Guo Y, Lip GY, Apostolakis S (2012) Inflammation in atrial fibrillation. J Am Coll Cardiol 60:2263–2270CrossRefPubMed
3.
go back to reference Fontes ML, Mathew JP, Rinder HM, Zelterman D, Smith BR, Rinder CS, the Multicenter Study of Perioperative Ischemia (McSPI) Reasearch Group (2005) Atrial fibrillation after cardiac surgery/cardiopulmonary bypass is associated with monocyte activation. Anesth Analg 101:17–23CrossRefPubMed Fontes ML, Mathew JP, Rinder HM, Zelterman D, Smith BR, Rinder CS, the Multicenter Study of Perioperative Ischemia (McSPI) Reasearch Group (2005) Atrial fibrillation after cardiac surgery/cardiopulmonary bypass is associated with monocyte activation. Anesth Analg 101:17–23CrossRefPubMed
4.
go back to reference Yamashita T, Sekiguchi A, Iwasaki Y, Date T, Sagara K, Tanabe H, Suma H, Sawada H, Aizawa T (2010) Recruitment of immune cells across atrial endocardium in human atrial fibrillation. Circ J 74:262–270CrossRefPubMed Yamashita T, Sekiguchi A, Iwasaki Y, Date T, Sagara K, Tanabe H, Suma H, Sawada H, Aizawa T (2010) Recruitment of immune cells across atrial endocardium in human atrial fibrillation. Circ J 74:262–270CrossRefPubMed
5.
go back to reference Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, Leenen PJ, Liu YJ, MacPherson G, Randolph GJ, Scherberich J, Schmitz J, Shortman K, Sozzani S, Strobl H, Zembala M, Austyn JM, Lutz MB (2010) Nomenclature of monocytes and dendritic cells in blood. Blood 116:e74–e80CrossRefPubMed Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, Leenen PJ, Liu YJ, MacPherson G, Randolph GJ, Scherberich J, Schmitz J, Shortman K, Sozzani S, Strobl H, Zembala M, Austyn JM, Lutz MB (2010) Nomenclature of monocytes and dendritic cells in blood. Blood 116:e74–e80CrossRefPubMed
6.
go back to reference Schlitt A, Heine GH, Blankenberg S, Espinola-Klein C, Dopheide JF, Bickel C, Lackner KJ, Iz M, Meyer J, Darius H, Rupprecht HJ (2004) CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. Thromb Haemost 92:419–424CrossRefPubMed Schlitt A, Heine GH, Blankenberg S, Espinola-Klein C, Dopheide JF, Bickel C, Lackner KJ, Iz M, Meyer J, Darius H, Rupprecht HJ (2004) CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. Thromb Haemost 92:419–424CrossRefPubMed
7.
go back to reference Suzuki A, Fukuzawa K, Yamashita T, Yoshida A, Sasaki N, Emoto T, Takei A, Fujiwara R, Nakanishi T, Yamashita S, Matsumoto A, Konishi H, Ichibori H, Hirata K (2017) Circulating intermediate CD14++CD16+ monocytes are increased in patients with atrial fibrillation and reflect the functional remodelling of the left atrium. Europace 19:40–47CrossRefPubMed Suzuki A, Fukuzawa K, Yamashita T, Yoshida A, Sasaki N, Emoto T, Takei A, Fujiwara R, Nakanishi T, Yamashita S, Matsumoto A, Konishi H, Ichibori H, Hirata K (2017) Circulating intermediate CD14++CD16+ monocytes are increased in patients with atrial fibrillation and reflect the functional remodelling of the left atrium. Europace 19:40–47CrossRefPubMed
8.
go back to reference Shishido T, Nozaki N, Yamaguchi S, Shibata Y, Nitobe J, Miyamoto T, Takahashi H, Arimoto T, Maeda K, Yamakawa M, Takeuchi O, Akira S, Takeishi Y, Kubota I (2003) Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. Circulation 108:2905–2910CrossRefPubMed Shishido T, Nozaki N, Yamaguchi S, Shibata Y, Nitobe J, Miyamoto T, Takahashi H, Arimoto T, Maeda K, Yamakawa M, Takeuchi O, Akira S, Takeishi Y, Kubota I (2003) Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. Circulation 108:2905–2910CrossRefPubMed
9.
go back to reference Eissler R, Schmaderer C, Rusai K, Kühne L, Sollinger D, Lahmer T, Witzke O, Lutz J, Heemann U, Baumann M (2011) Hypertension augments cardiac Toll-like receptor 4 expression and activity. Hypertens Res 34:551–558CrossRefPubMed Eissler R, Schmaderer C, Rusai K, Kühne L, Sollinger D, Lahmer T, Witzke O, Lutz J, Heemann U, Baumann M (2011) Hypertension augments cardiac Toll-like receptor 4 expression and activity. Hypertens Res 34:551–558CrossRefPubMed
10.
go back to reference Gurses KM, Kocyigit D, Yalcin MU, Canpinar H, Yorgun H, Sahiner ML, Kaya EB, Oto MA, Ozer N, Guc D, Aytemir K (2016) Monocyte toll-like receptor expression in patients with atrial fibrillation. Am J Cardiol 117:1463–1467CrossRefPubMed Gurses KM, Kocyigit D, Yalcin MU, Canpinar H, Yorgun H, Sahiner ML, Kaya EB, Oto MA, Ozer N, Guc D, Aytemir K (2016) Monocyte toll-like receptor expression in patients with atrial fibrillation. Am J Cardiol 117:1463–1467CrossRefPubMed
11.
go back to reference Kottkamp H (2013) Human atrial fibrillation substrate: towards a specific fibrotic atrial cardiomyopathy. Eur Heart 34:2731–2738CrossRef Kottkamp H (2013) Human atrial fibrillation substrate: towards a specific fibrotic atrial cardiomyopathy. Eur Heart 34:2731–2738CrossRef
12.
go back to reference Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, Kholmovski E, Burgon N, Hu N, Mont L, Deneke T, Duytschaever M, Neumann T, Mansour M, Mahnkopf C, Herweg B, Daoud E, Wissner E, Bansmann P, Brachmann J (2014) Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA 311:498–506CrossRefPubMed Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, Kholmovski E, Burgon N, Hu N, Mont L, Deneke T, Duytschaever M, Neumann T, Mansour M, Mahnkopf C, Herweg B, Daoud E, Wissner E, Bansmann P, Brachmann J (2014) Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA 311:498–506CrossRefPubMed
13.
go back to reference Verma A, Wazni OM, Marrouche NF, Martin DO, Kilicaslan F, Minor S, SchweikertSaliba RAW, Cummings J, Burkhardt JD, Bhargava M, Belden WA, Abdul-Karim A, Natale A (2005) Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. J Am Coll Cardiol 45:285–292CrossRef Verma A, Wazni OM, Marrouche NF, Martin DO, Kilicaslan F, Minor S, SchweikertSaliba RAW, Cummings J, Burkhardt JD, Bhargava M, Belden WA, Abdul-Karim A, Natale A (2005) Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. J Am Coll Cardiol 45:285–292CrossRef
14.
go back to reference Miyamoto K, Tsuchiya T, Narita S, Yamaguchi T, Nagamoto Y, Ando S, Hayashida K, Tanioka Y, Takahashi N (2009) Bipolar electrogram amplitudes in the left atrium are related to local conduction velocity in patients with atrial fibrillation. Europace 11:1597–1605CrossRefPubMed Miyamoto K, Tsuchiya T, Narita S, Yamaguchi T, Nagamoto Y, Ando S, Hayashida K, Tanioka Y, Takahashi N (2009) Bipolar electrogram amplitudes in the left atrium are related to local conduction velocity in patients with atrial fibrillation. Europace 11:1597–1605CrossRefPubMed
15.
go back to reference Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN, Blauer JJ, Rao SN, DiBella EV, Segerson NM, Daccarett M, Windfelder J, McGann CJ, Parker D, MacLeod RS, Marrouche NF (2009) Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 119:1758–1767CrossRefPubMed Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN, Blauer JJ, Rao SN, DiBella EV, Segerson NM, Daccarett M, Windfelder J, McGann CJ, Parker D, MacLeod RS, Marrouche NF (2009) Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 119:1758–1767CrossRefPubMed
16.
go back to reference Yoshida N, Emoto T, Yamashita T, Watanabe H, Hayashi T, Tabata T, Hoshi N, Hatano N, Ozawa G, Sasaki N, Mizoguchi T, Amin HZ, Hirota Y, Ogawa W, Yamada T, Hirata K (2018) Bacteroides vulgatus and Bacteroides dorei reduce gut microbial lipopolysaccharide production and inhibit atherosclerosis. Circulation 138:2486–2498CrossRefPubMed Yoshida N, Emoto T, Yamashita T, Watanabe H, Hayashi T, Tabata T, Hoshi N, Hatano N, Ozawa G, Sasaki N, Mizoguchi T, Amin HZ, Hirota Y, Ogawa W, Yamada T, Hirata K (2018) Bacteroides vulgatus and Bacteroides dorei reduce gut microbial lipopolysaccharide production and inhibit atherosclerosis. Circulation 138:2486–2498CrossRefPubMed
17.
go back to reference Mahnkopf C, Badger TJ, Burgon NS, Daccarett M, Haslam TS, Badger CT, McGann CJ, Akoum N, Kholmovski E, Macleod RS, Marrouche NF (2010) Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation. Heart Rhythm 7:1475–1481CrossRefPubMed Mahnkopf C, Badger TJ, Burgon NS, Daccarett M, Haslam TS, Badger CT, McGann CJ, Akoum N, Kholmovski E, Macleod RS, Marrouche NF (2010) Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation. Heart Rhythm 7:1475–1481CrossRefPubMed
18.
go back to reference Yamaguchi T, Tsuchiya T, Nagamoto Y, Miyamoto K, Murotani K, Okishige K, Takahashi N (2014) Long-term results of pulmonary vein antrum isolation in patients with atrial fibrillation: an analysis in regards to substrates and pulmonary vein reconnections. Europace 16:511–520CrossRefPubMed Yamaguchi T, Tsuchiya T, Nagamoto Y, Miyamoto K, Murotani K, Okishige K, Takahashi N (2014) Long-term results of pulmonary vein antrum isolation in patients with atrial fibrillation: an analysis in regards to substrates and pulmonary vein reconnections. Europace 16:511–520CrossRefPubMed
19.
go back to reference Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A (1997) Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96:1180–1184CrossRefPubMed Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A (1997) Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96:1180–1184CrossRefPubMed
20.
go back to reference Kume O, Teshima Y, Abe I, Ikebe Y, Oniki T, Kondo H, Saito S, Akira Fukui A, Yufu K, Miura M, Shimada T, Takahashi N (2017) Role of atrial endothelial cells in the development of atrial fibrosis and fibrillation in response to pressure overload. Cardiovasc Pathol 27:18–25CrossRefPubMed Kume O, Teshima Y, Abe I, Ikebe Y, Oniki T, Kondo H, Saito S, Akira Fukui A, Yufu K, Miura M, Shimada T, Takahashi N (2017) Role of atrial endothelial cells in the development of atrial fibrosis and fibrillation in response to pressure overload. Cardiovasc Pathol 27:18–25CrossRefPubMed
21.
go back to reference McGann C, Akoum N, Patel A, Kholmovski E, Revelo P, Damal K, Wilson B, Cates J, Harrison A, Ranjan R, Burgon NS, Greene T, Kim D, Dibella EVR, Parker D, Macleod RS, Marrouche NF (2014) Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ Arrhythm Electrophysiol 7:23–30CrossRefPubMed McGann C, Akoum N, Patel A, Kholmovski E, Revelo P, Damal K, Wilson B, Cates J, Harrison A, Ranjan R, Burgon NS, Greene T, Kim D, Dibella EVR, Parker D, Macleod RS, Marrouche NF (2014) Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ Arrhythm Electrophysiol 7:23–30CrossRefPubMed
22.
go back to reference Metcalf TU, Wilkinson PA, Cameron MJ, Ghneim K, Chiang C, Wertheimer AM, Hiscott JB, Nikolich-Zugich J, Haddad EK (2017) Monocyte subsets are transcriptionally and functionally altered in aging in response to pattern recognition receptor agonists. J Immunol 199:1405–1417CrossRefPubMed Metcalf TU, Wilkinson PA, Cameron MJ, Ghneim K, Chiang C, Wertheimer AM, Hiscott JB, Nikolich-Zugich J, Haddad EK (2017) Monocyte subsets are transcriptionally and functionally altered in aging in response to pattern recognition receptor agonists. J Immunol 199:1405–1417CrossRefPubMed
23.
go back to reference Gordon JW, Shaw JA, Kirshenbaum LA (2011) Multiple facets of NF-κB in the heart: to be or not to NF-κB. Circ Res 108:1122–1132CrossRefPubMed Gordon JW, Shaw JA, Kirshenbaum LA (2011) Multiple facets of NF-κB in the heart: to be or not to NF-κB. Circ Res 108:1122–1132CrossRefPubMed
24.
go back to reference Liu Y, Niu XH, Yin X, Liu Y, Han C, Yang J, Huang X, Yu X, Gao L, Yang YZ, Xia YL, Li HH (2018) Elevated circulating fibrocytes is a marker of left atrial fibrosis and recurrence of persistent atrial Fibrillation. J Am Heart Assoc 7:e008083PubMed Liu Y, Niu XH, Yin X, Liu Y, Han C, Yang J, Huang X, Yu X, Gao L, Yang YZ, Xia YL, Li HH (2018) Elevated circulating fibrocytes is a marker of left atrial fibrosis and recurrence of persistent atrial Fibrillation. J Am Heart Assoc 7:e008083PubMed
25.
go back to reference Heinzmann D, Fuß S, Ungern-Sternberg SV, Schreieck J, Gawaz M, Gramlich M, Seizer P (2018) TGFβ is specifically upregulated on circulating CD14++ CD16+ and CD14+ CD16++ monocytes in patients with atrial fibrillation and severe atrial fibrosis. Cell Physiol Biochem 49:226–234CrossRefPubMed Heinzmann D, Fuß S, Ungern-Sternberg SV, Schreieck J, Gawaz M, Gramlich M, Seizer P (2018) TGFβ is specifically upregulated on circulating CD14++ CD16+ and CD14+ CD16++ monocytes in patients with atrial fibrillation and severe atrial fibrosis. Cell Physiol Biochem 49:226–234CrossRefPubMed
26.
go back to reference Yamamoto T, Umegae S, Matsumoto K (2006) Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis. World J Gastroenterol 12:520–525CrossRefPubMed Yamamoto T, Umegae S, Matsumoto K (2006) Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis. World J Gastroenterol 12:520–525CrossRefPubMed
27.
go back to reference Yuan X, Deng Y, Guo X, Shang J, Zhu D, Liu H (2014) Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: partly involvement of TLR-4/MYD88 pathway. Biochem Biophys Res Commun 446:292–297CrossRefPubMed Yuan X, Deng Y, Guo X, Shang J, Zhu D, Liu H (2014) Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: partly involvement of TLR-4/MYD88 pathway. Biochem Biophys Res Commun 446:292–297CrossRefPubMed
28.
go back to reference Bertocchi C, Traunwieser M, Dörler J, Hasslacher J, Joannidis M, Dunzendorfer S (2011) Atorvastatin inhibits functional expression of proatherogenic TLR2 in arterial endothelial cells. Cell Physiol Biochem 28:625–630CrossRefPubMed Bertocchi C, Traunwieser M, Dörler J, Hasslacher J, Joannidis M, Dunzendorfer S (2011) Atorvastatin inhibits functional expression of proatherogenic TLR2 in arterial endothelial cells. Cell Physiol Biochem 28:625–630CrossRefPubMed
Metadata
Title
Circulating intermediate monocytes and toll-like receptor 4 correlate with low-voltage zones in atrial fibrillation
Authors
Hideya Suehiro
Koji Fukuzawa
Naofumi Yoshida
Kunihiko Kiuchi
Mitsuru Takami
Tomomi Akita
Tokiko Tabata
Makoto Takemoto
Jun Sakai
Toshihiro Nakamura
Atsusuke Yatomi
Hiroyuki Takahara
Yusuke Sonoda
Kazutake Nakasone
Kyoko Yamamoto
Atsushi Suzuki
Tomoya Yamashita
Ken-ichi Hirata
Publication date
01-12-2020
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 12/2020
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-020-01647-4

Other articles of this Issue 12/2020

Heart and Vessels 12/2020 Go to the issue